Cogent Biosciences (COGT) Earnings Date, Estimates & Call Transcripts $5.99 +0.35 (+6.21%) Closing price 06/5/2025 04:00 PM EasternExtended Trading$5.92 -0.08 (-1.25%) As of 06/5/2025 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cogent Biosciences Earnings Summary Cogent Biosciences issued Q1 2025 earnings on May 6, 2025, reporting an EPS of -$0.52, which beat the consensus estimate of -$0.56 by $0.04. With a trailing EPS of -$1.84, Cogent Biosciences' earnings are expected to grow next year, from ($2.42) to ($2.20) per share. Upcoming Q2 Earnings DateAug. 5Before Market OpensEstimatedConsensus EPS (May. 6) -$0.56 Actual EPS (May. 6) -$0.52 Beat By $0.04 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)COGT Upcoming EarningsCogent Biosciences' next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules. Powered by Get Cogent Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cogent Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCOGT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Cogent Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.65-$0.44-$0.55Q2 20253-$0.63-$0.39-$0.53Q3 20253-$0.59-$0.38-$0.51Q4 20253-$0.57-$0.37-$0.50 Cogent Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/5/2025(Estimated)--------5/6/2025Q1 2025-$0.56-$0.52+$0.04-$0.52--11/12/2024Q3 2024-$0.57-$0.64 -$0.07-$0.64--8/6/2024Q2 2024-$0.56-$0.59 -$0.03-$0.59--5/7/2024Q1 2024-$0.51-$0.62 -$0.11-$0.62--2/26/2024Q4 2023-$0.55-$0.63 -$0.08-$0.63--11/2/2023Q3 2023-$0.50-$0.64 -$0.14-$0.64--8/8/2023Q2 2023-$0.53-$0.59 -$0.06-$0.59-- Cogent Biosciences Earnings - Frequently Asked Questions When is Cogent Biosciences's earnings date? Cogent Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on COGT's earnings history. Did Cogent Biosciences beat their earnings estimates last quarter? In the previous quarter, Cogent Biosciences (NASDAQ:COGT) reported ($0.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.56) by $0.04. Learn more on analysts' earnings estimate vs. COGT's actual earnings. How much profit does Cogent Biosciences generate each year? Cogent Biosciences (NASDAQ:COGT) has a recorded net income of -$192.41 million. COGT has generated -$1.84 earnings per share over the last four quarters. What is Cogent Biosciences's EPS forecast for next year? Cogent Biosciences's earnings are expected to grow from ($2.42) per share to ($2.20) per share in the next year. More Earnings Resources from MarketBeat Related Companies LYEL Earnings Results APLS Earnings Results OGN Earnings Results IBRX Earnings Results AMRX Earnings Results XENE Earnings Results MIRM Earnings Results ARWR Earnings Results NAMS Earnings Results BLTE Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Red Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode DealCrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings This page (NASDAQ:COGT) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredHow to target 627% gains from Trump’s tweetsPresident Trump is shaking up the market with his tweets and Truth Social posts... But while this chaos has...Monument Traders Alliance | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredTrump plotting new lockdown?It's listed inside the White House's own documents: Federal Register notice 90 FR 4544 to be exact. And wh...Porter & Company | SponsoredWhy hasn't Elon tweeted about this?Behind the scenes, there's an entirely different Tesla story brewing… . It's about a quiet stream of income...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
